Kyntra Bio (KYNB) Tax Rate (2015 - 2026)

Kyntra Bio (KYNB) posted Tax Rate of 83.18% for Q4 2025, up 12353.78% sequentially from 0.67% in Q2 2025, and up 8320.0% YoY from 0.99% in Q4 2024.

Kyntra Bio (KYNB) Tax Rate (2015 - 2026) Analysis & Trends

Kyntra Bio has reported Tax Rate for 11 years, with the latest figure at 83.18% in Q4 2025.

Quarterly Tax Rate rose 8320.0% year-over-year to 83.18% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 21.61% (up 2138.0% YoY) and the FY2025 annual result came in at 21.0%, up 2083.0% from the prior year.
Tax Rate improved to 83.18% in Q4 2025 per KYNB's latest filing, from 0.67% in the prior quarter.
Over five years, Tax Rate peaked at 83.18% in Q4 2025 and troughed at 0.19% in Q1 2021.
A 5-year average of 4.42% and a median of 0.01% in 2024 frame the typical range for Tax Rate.
The sharpest annual moves came in 2021 and 2025: Tax Rate sank 43 bps in 2021, then soared 8320 bps in 2025.
Over 5 years, Tax Rate stood at 0.08% in 2021, then tumbled by 95 bps to 0.16% in 2022, then soared by 215 bps to 0.19% in 2023, then sank by 112 bps to 0.02% in 2024, then jumped by 360376 bps to 83.18% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 83.18%, 0.67%, and 0.01% for Q4 2025, Q2 2025, and Q1 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	15.11%
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	10.91%
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-1.96%
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	24.15%
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	7.49%
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	34.12%
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-16.71%
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Kyntra Bio	30.42 Mn	30.42 Mn	1.47 Mn	-0.01%

Download Data